Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

High-level surfactin production by Bacillus subtilis through integrated metabolic engineering and bioprocess optimization.

Surfactin is a cyclic lipopeptide biosurfactant produced by Bacillus species and has considerable potential as a sustainable alternative to petroleum-derived surfactants. However, efficient surfactin production remains constrained by the limited productivity of native strains, inadequate precursor supply and suboptimal fermentation conditions. In this study, Bacillus subtilis ATCC 6051a, which harbors an intact endogenous sfp gene, was used as the strain background to develop a high-producing surfactin production system through integrated strain engineering and fermentation optimization. Building on a previously established T7 RNA polymerase expression platform, deletion of codY and spoIIAC together with mutation of abrB generated strain 164LP4, which produced 286mg/L surfactin. Subsequent enhancement of comA, sfp and srfA expression further improved surfactin biosynthesis, with T7 promoter-driven expression of the srfA operon in strain 164LP7-1 increasing the titer to 1.75g/L. Optimization of the cultivation conditions further increased surfactin production to 4.69g/L, while combined supplementation with L-leucine and sodium glutamate markedly increased the titer to 13.62g/L. Further engineering of fatty acid precursor metabolism and secretion-related processes, including enhanced cypC and secA expression, yielded strain 164LP15, which reached a shake-flask surfactin titer of 19.22g/L. In a 5-L fed-batch bioreactor, 164LP15 produced 52.32g/L surfactin within 27h, corresponding to an average productivity of 1.94g/L/h. The integration of multi-level strain engineering with fermentation optimization thus established B. subtilis ATCC 6051a as an effective platform for high-level surfactin production and provides a practical framework for the development of efficient microbial surfactin production systems.

Ai Chen, Yu-Kang Xie, Min Liu et al. · 0 citations
Sep 2026

Engineering of central metabolism for high-yield 1,3-propanediol production using co-substrates by Klebsiella pneumoniae.

1,3-Propanediol is a versatile C3 diol serving as a key building block used in various industries. Klebsiella pneumoniae represents an attractive microbial chassis for 1,3-PDO production due to its endogenous 1,3-PDO and Vitamin B₁₂ biosynthetic pathways. However, low carbon flux and by-product formation remain bottlenecks to high-efficiency 1,3-PDO production. Here, a novel co-substrate (glucose-glycerol) strategy was reported to address these limitations. First, the glycerol oxidation and 3-hydroxypropionic acid biosynthetic pathways were eliminated, driving glycerol to serve exclusively as the substrate for 1,3-PDO synthesis. Glucose was then dedicated to support cell growth and energy generation. To maximize glucose-to-energy conversion, the pentose phosphate pathway, Entner-Doudoroff pathway, Embden-Meyerhof-Parnas pathway, and tricarboxylic acid cycle were systematically engineered. The engineered strain KPS8-6 produced 18.8g/L of 1,3-PDO in shake flask cultivations, with a yield of 0.97mol/mol glycerol, and 1 mole of glucose supported the production of 4.27 mole of 1,3-PDO. 91.62g/L 1,3-PDO was produced after 60h of cultivation in fed-batch fermentations, and the yield of 1,3-PDO from glycerol was 0.99mol/mol. This work establishes a robust, co-substrate-driven strategy for high-yield 1,3-PDO production.

Shao-Qi Sun, Ai Chen, Wen-Qi Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.